- $20.07m
- $0.84m
- $2.39m
- 43
- 25
- 22
- 20
Annual income statement for Longeveron, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.63 | 1.31 | 1.22 | 0.709 | 2.39 |
| Cost of Revenue | |||||
| Gross Profit | 1.83 | 0.59 | 0.497 | 0.221 | 1.88 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 9.41 | 18.5 | 19.3 | 22 | 18.9 |
| Operating Profit | -3.78 | -17.2 | -18 | -21.3 | -16.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.72 | -17 | -18.8 | -21.4 | -16 |
| Net Income After Taxes | -3.72 | -17 | -18.8 | -21.4 | -16 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.72 | -17 | -18.8 | -21.4 | -16 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.72 | -17 | -18.8 | -22.2 | -24.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.99 | -9.17 | -8.98 | -10.1 | -2.62 |
| Dividends per Share |